Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Athersys, Inc. (ATHX)

-NasdaqCM
1.29 Down 0.03(2.27%) Apr 24, 4:00PM EDT
|After Hours : 1.29 0.00 (0.00%) Apr 24, 4:40PM EDT
Add to Portfolio
Prev Close:1.32
Open:1.31
Bid:1.26 x 3000
Ask:1.30 x 5000
1y Target Est:5.50
Beta:-0.02
Next Earnings Date:11-May-15ATHX Earnings announcement
Day's Range:1.26 - 1.32
52wk Range:0.90 - 3.43
Volume:1,615,017
Avg Vol (3m):2,062,390
Market Cap:103.50M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):65.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.31
Quarterly EPS Est (Mar-15) :-0.09
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback